New Cannabis Patch to Treat Fibromyalgia and Diabetic Nerve Pain Revealed

Thanks to a company whose specialization is the medical use of cannabis, today we have the revolutionary cannabis pain patch that can be used to treat diabetic nerve pain and symptoms of fibromyalgia. This innovation is a total game changer in the medical world!

This new way or administering cannabis is through transdermal patches. The patches are simply stuck on the skin and release certain chemicals over time to help combat neurological nerve pain associated with diabetes and fibromyalgia. This way, the dosages are controlled and the medication can be administered on a daily basis with no negative side effects discovered so far.

Cannabis Science, the company who originally designed the patches, said:

“Promote healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive which will be containing high potency cannabinoid (CBD) extract that slowly enters into the bloodstream and then penetrates the central nervous system of the patient delivering the pain relief sought.”

After THC, CBD is the second cannabinoid contained in cannabis which can relive pain, has anti-inflammatory properties and comes from a completely natural source with very few side effects, including the hallucinogenic effects commonly associated with THC.

“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science. While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications,” says Mr Raymond C Dabney, CEO of Cannabis Science.

10% of the people suffer from fibromyalgia, and this percent represents only the known cases. Nerve neuropathy diabetic pain also affects a great number of people all over the world, and these revolutionary patches are a great step forward towards limiting certain symptoms, and maybe even curing these illnesses for good.

“As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years,” Mr Dabney concludes.